Revisión datos de PANITUMUMAB en función de la localización del tumor - page 40

CRYSTAL FIRE 3 CLAGB
80405
PRIME PEAK TAULI
SLP DCHO
NO AC
ANTIEGFR
Beva
P:0.66
HR:0.87
7.1m
8.1m
P:0.11
HR:1.44
7.6m
9.0m
P:0.006
HR:1.64
7.5m
10.2m
P:
HR:0.80
7.0m
7.5m
P:
HR:0.84
8.7m
12.6m
P:
HR:
9.0m
9.0m
6.0m
SG DCHO
NO AC
ANTIEGFR
Beva
P:1.08
HR:0.76
15.0m
18.5m
P:0.28
HR:1.31
18.3m
23.0m
P:1.10
HR:1.36
13.7m
29.2m
P:
HR:0.87
15.4m
11.2m
P:
HR:0.45
17.5m
21.0m
P:
HR:
22.0m
11.0m
32.0m
Comparativo estudios: Colon Derecho